In the Media

BioMed X Start Collaboration in Autoimmunity Research with Servier

BioSpace

BioMed X Start Collaboration in Autoimmunity Research with Servier

MarketWatch

BioMed X hilft Boehringer und expandiert in die USA

Transkript

Das private Forschungsinstitut BioMed X in Heidelberg meldet erfolgreiche Forschungskooperationen mit der Industrie und expandiert in die USA nach New Haven.

BioMed X Launches New US Institute in New Haven, CT

Newsfile

Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.

BioMed X Launches New US Institute in New Haven, CT

PharmiWeb

The new institute is managed by Mark Johnston, an experienced biotech CEO and entrepreneur. “We are so grateful for all the local support. New Haven is such a vibrant life sciences hub, coming here was the right choice for us,” explains Johnston.

BioMed X Launches New US Institute in New Haven, CT

BioSpace

Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.

BioMed X Institute: BioMed X Launches New US Institute in New Haven, CT

FinanzNachrichten

BioMed X, an independent research institute founded in Heidelberg, Germany, has expanded its operations with the opening of a new institute in the United States. Located in New Haven, CT, in the vicinity of Yale University, the new facilities are part of the Elm City Bioscience Center.

BIOMED X LAUNCHES NEW US INSTITUTE IN NEW HAVEN, CT

Yale Ventures

Yale Ventures Managing Director Josh Geballe took part in the opening ceremony on Tuesday and expressed his excitement for the collaboration potential that BioMed X brings to New Haven: “Yale is committed to global partnerships that foster innovation. We warmly welcome BioMed X to our bio-ecosystem and are looking forward to future collaborations.”

BioMed X Launches New US Institute in New Haven, CT

Yahoo! Finance

Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.

BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project

PharmiWeb

The data resulting from this project have been acquired by Boehringer Ingelheim, where this research will be continued, potentially paving the way for novel therapies.

BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project

MarketWatch

The research of BioMed X team EPD – Early Intervention in Psychiatric Diseases – has shed light on the molecular mechanisms underlying white matter deficits in schizophrenia.

BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project

FinanzNachrichten

German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders.

BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project

Yahoo! Finance

The research of BioMed X team EPD – Early Intervention in Psychiatric Diseases – has shed light on the molecular mechanisms underlying white matter deficits in schizophrenia.